US vs Korea Cancer Treatment Cost (2026): Every Number Sourced
Why there is no honest single number for "US cancer treatment cost"
Costs depend on cancer type, stage, and payer. What is documented:
- Uninsured patients are commonly billed at hospital chargemaster rates, for outpatient chemotherapy drugs these ran 2 to 43 times what Medicare pays (PMC, 2016).
- Cancer drugs commonly run $1,000–$12,000+ per month (President's Cancer Panel, 2018).
- A radiation course: about $15,000–$50,000; six months of chemotherapy: about $10,000–$65,000+ uninsured (TreatCancer).
- Major cancer surgery: roughly $25,000–$120,000 depending on procedure and hospital (component estimate; see surgery lines below).
Sum of components ≈ $50,000–$235,000 for a surgery + chemo + radiation path. That is the range this page uses, built up, not asserted.
What the same categories cost in Korea (international patients)
| Treatment | Korea (international rate) | US (uninsured, cited range) | Sources |
|---|---|---|---|
| Gastrectomy (stomach cancer surgery) | Quoted per case — no published rate we can cite | part of $25k–120k surgery range | Hospital estimate required |
| Robotic (da Vinci) cancer surgery | Quoted per case — no published rate we can cite | — | Hospital estimate required |
| Carbon-ion radiotherapy (course) | ~₩50,000,000 (~$36,000), Yonsei | not available in the US (no operating carbon-ion center) | Korea Biomedical Review |
| Remote written second opinion | ₩320,000 (~$230), Asan, 5–10 business days | usually unpublished / employer-benefit access | AMC official · Cleveland Clinic |
Price honesty: Korean hospitals bill foreigners at international rates, at one major center about 3× domestic insured rates (KBR, 2025). We publish only prices we can trace to a hospital’s own disclosure or Korea’s national non-covered price-disclosure system — never to a booking aggregator. Where no such published rate exists, this table says so instead of estimating. A real number requires your records reviewed by the hospital, get a written pre-treatment estimate before traveling. Flights, lodging, and a companion add real cost; budget them explicitly.
Speed: the other price
- US median time from diagnosis to first treatment: 34 days (2015) → 44 days (2022), still rising (JNCI).
- Korea: in a national gastric-cancer cohort, 71.2% had surgery within 30–50 days of diagnosis (PMC, 2021); Samsung's breast center runs same-day imaging and staging on first visit (SMC).
Quality: what's real, what's screening effect
- Rankings: Newsweek 2026 global oncology top 10 includes three Seoul hospitals, Samsung #3, Asan #4, SNUH #8 (Newsweek).
- Mortality: Korea has the lowest cancer death rate among major countries, 64.3/100k vs 82.3 (US), 2023 (Cancer Res Treat 2026).
- Survival, honestly framed: Korea's 5-year stomach-cancer survival (78.6%) roughly doubles the US figure (39.8%) (KCCR · SEER). But much of that gap is earlier detection through national screening, not surgery alone (IARC). Stage-matched comparisons with a top US center show mixed results (Ann Surg 2010: Korea better after risk adjustment; Ann Surg Oncol 2014: no difference in an early-stage subgroup). The cleanest large gap is liver cancer: 40.4% vs 21.9% 5-year survival.
- Volume: a high-volume Korean gastric center performs ~500 gastrectomies/year (PMC); the US "high-volume" threshold is 17/year, and 92% of US patients are treated below it (PubMed).
Why this matters more in 2026
- ACA enhanced subsidies expired at the end of 2025; average marketplace premium payments rose about 114% (KFF).
- CBO projects +3.8 million uninsured per year (2026–34) (CRS).
- For newly uninsured patients facing chargemaster billing, the cross-border math above stops being exotic and starts being arithmetic.
FAQ
Can I just get a quote from a Korean hospital?
Yes, international offices at major centers respond to record submissions with estimates (Severance targets ~24-hour quote turnaround: Severance IHC). The lowest-commitment first step is a written second opinion (Asan, ₩320,000), see our step-by-step guide.
Do Americans actually do this?
In 2024, Korea treated 7,147 international cancer patients; the US was the #2 country of origin (1,341 patients, 18.8%) (KHIDI 2024 statistics). Overall foreign patients reached 1.17 million (+93.2% YoY) (Ministry of Health and Welfare).
What can go wrong?
Real risks: travel while ill, coordination between your US and Korean physicians, follow-up care continuity, and complication management after returning home. Any serious plan needs your local oncologist informed, records flowing both ways, and a follow-up protocol. This is exactly the coordination layer services like ANDO exist to run.